The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than
29 million people and has caused more than 900,000 deaths worldwide as of September …

Recent retrospective studies of severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2) disease (COVID‐19) revealed that the patients with common comorbidities of …

Background Coronavirus disease 2019 (COVID-19) was first detected in patients with
pneumonia in December 2019 in China and it spread rapidly to the rest of the world …

Background The new coronavirus pneumonia (NCP) is now causing a severe public health
emergency. The novel coronavirus 2019 (2019-nCoV) infected individuals by binding …

In 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused
infections worldwide. However, the correlation between the immune infiltration and …

Because ACE2 is a host cell receptor of the SARS-CoV-2, an investigation of ACE2
expression in normal and virus-infected human tissues is crucial for understanding the …

Abstract The novel coronavirus (2019-nCoV) is an emerging causative agent that was first
described in late December 2019 and causes a severe respiratory infection in humans …

COVID-19 is a pandemic that began to spread worldwide caused by SARS-CoV-2. Lung
cancer patients are more susceptible to SARS-CoV-2 infection. The SARS-CoV-2 enters into …

To explore the potential mechanism of cancer patients appearing more vulnerable to SARS-
CoV-2 infection and poor COVID-19 outcomes, we conducted an integrative bioinformatics …

Abstract Novel coronavirus disease (COVID-19) pandemic has become a global health
emergency. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interacts with …